Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHEA add-on treatment for sexual functioning in women using oral contraceptives
ISRCTN03247616Phase 2Completed
- Sponsor
- Pantarhei Bioscience
- Start
- May 2007
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dehydroepiandrosterone, ethinylestradiol + levonorgestrel and drospirenone in sexual dysfunction (4 arms), sponsored by Pantarhei Bioscience. Primary endpoints: Sexual arousability, sexual desire, and frequency of sexual fantasies, Sexual function and 1 more. Started May 2007; status: completed.
02
Drugs
dehydroepiandrosteroneethinylestradiol + levonorgestreldrospirenone
03
Conditions
sexual dysfunction
Beyond the preview
Go deeper on ISRCTN03247616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN03247616.